Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Jun 14, 2020 9:00 AM - Jun 18, 2020 5:00 PM

(Eastern Standard Time)

Fort Washington, PA 19034

DIA 2020 Global Annual Meeting

Should a COVID-19 Vaccination be Legally Mandated and Can HTA Inform That Decision?

Session Chair(s)

Richard Hiraiwa Stanford, PHARMD, MS

Richard Hiraiwa Stanford, PHARMD, MS

Vice President, Strategic Consulting, AESARA, United States

Health Technology Assessment (HTA) is defined as a multidisciplinary process to evaluate the social, economic, organizational and ethical issues of an intervention or health technology. In anticipation of COVID-19 vaccine, a panel composed of the relevant stakeholders will have an open dialogue about the role of HTA in informing public health policy-making, with particular focus on vaccination, and enforcing such policies at an individual country and global levels. Potential learnings from previous pandemics, such as H1N1, will be reviewed. Ethical and economic challenges will be debated to offer a consensus position that takes into account societal benefits, economic, logistical and legal considerations.

Learning Objective : Debate the ethical, logistical, and legal implications if a mandated vaccine program were to be instituted and what would inform such a decision; Discuss the role and opportunity of HTA to inform and recommend a decision.

Speaker(s)

Richard Hiraiwa Stanford, PHARMD, MS

Panelist

Vice President, Strategic Consulting, AESARA, United States

Phil  Ball, PHD

Panelist

Health Policy, Biopharmaceutical Development Strategy, Independent Consultant, United States

Andrew H. Briggs, PHD, MSC

Panelist

Professor of Health Economics, London School of Hygiene and Tropical Medicine (LSHTM), United Kingdom

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.